NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO UNITED STATES NEWS AGENCIES

Alaris Royalty Corp. ("Alaris" or the "Corporation") (TSX:AD) is pleased to announce that Centric Health Corporation ("Centric") has redeemed (the "Redemption") a further portion of the preferred partnership units ("LifeMark Units") of LifeMark Health Limited Partnership ("LifeMark") held by Alaris, for aggregate gross proceeds of $7.5 million (the "Proceeds").

Pursuant to the terms of the LifeMark Units, the annual distribution payable to Alaris (The "Distribution") will increase by 4% on July 1st of every year for so long as the LifeMark Units remain outstanding. Therefore, after giving effect to this year's 4% increase, and the Redemption, the Distribution to Alaris will be $3.96 million on an annualized basis as of July 1, 2013. The redemption value of the remaining LifeMark Units is now $35.5 million. This value will also increase by 4% on June 9th of every year (beginning on June 9, 2014) for so long as the LifeMark Units remain outstanding. In accordance with the terms of the LifeMark Units, Centric has the right to fully redeem the remaining LifeMark Units held by Alaris at any time upon 30 days written notice.

Prior to the Redemption, Alaris had approximately $31.0 million of debt drawn on its $50.0 million credit facility (the "Facility"). The Corporation will use the Proceeds from today's Redemption to reduce the balance outstanding on the Facility, leaving an undrawn balance of approximately $26.5 million to use for future contributions to new or existing private company partners.

About Alaris

The Corporation provides alternative financing to a diversified group of private businesses ("Private Company Partners") in exchange for royalties or distributions from the Private Company Partners, with the principal objective of generating stable and predictable cash flows for dividend payments to its shareholders. Royalties or distributions to Alaris from the Private Company Partners are structured as a percentage of a "top line" financial performance measure such as gross margin, same clinic sales, gross revenues and same-store sales and rank in priority to the owners' common equity position.

Forward-Looking Statements

This news release contains forward-looking statements or forward-looking information (collectively, "forward-looking statements") as defined by applicable securities legislation. Statements other than statements of historical fact contained in this news release may be forward-looking statements, including, without limitation, management's expectations, intentions, beliefs and statements concerning the Distribution and increases thereto, the redemption value of the remaining LifeMark Units held by Alaris, the use of the Proceeds, the Company's ability to reinvest the Proceeds in new and existing partnerships and the repayment of debt under the Facility. Many of these statements can be identified by looking for words such as "believe", "expects", "will", "intends", "projects", "anticipates", "estimates", "continues" or similar words or the negative thereof. There can be no assurance that the plans, intentions or expectations upon which these forward looking statements are based will occur.

Forward-looking statements by their nature involve numerous assumptions and significant known and unknown facts and uncertainties of both a general and a specific nature. Key assumptions include, but are not limited to assumptions that: the Canadian and U.S. economies will continue to grow moderately in 2013; the Company will be able to identify and close new opportunities with new and existing Private Company Partners; interest rates will remain stable; more private companies will require access to alternative sources of capital; and capital markets will continue to improve. In determining the Company's expectations for economic growth, management primarily considers historical economic data provided by the Canadian and U.S. governments and their agencies.

Forward-looking statements are subject to risks, uncertainties and assumptions and should not be read as guarantees or assurances of future performance. Accordingly, readers are cautioned not to place undue reliance on any forward-looking statements contained in this news release as a number of factors could cause actual future results, conditions, actions or events to differ materially from the targets, expectations, estimates or intentions expressed in the forward-looking statements. Such factors include, without limitation, risks associated with: the general economic conditions in Canada, the United States and globally; the dependence of Alaris on the Private Company Partners; reliance on key personnel; failure to complete or realize the anticipated benefits of Alaris' arrangements with the Private Company Partners; limited diversification of the Private Company Partners; management of future growth; availability of future financing; competition; government regulation; leverage and restrictive covenants under the Facility; the ability of the Private Company Partners to terminate their agreements with the Company; the Private Company Partners' ability to continue to pay the distributions to Alaris; risks relating to the Private Company Partners and their businesses; fluctuations of dividends; restrictions on the potential growth of Alaris as a consequence of the payment by Alaris of substantially all of its operating cash flow; income tax related risks; ability to recover from the Private Company Partners for defaults under its agreements therewith (as defined herein). The information set forth under the heading "Risk Factors" in the Company's Annual Information Form dated March 13, 2013 (a complete copy of which can be found on SEDAR at www.sedar.com) identifies additional factors that could affect the operating results and performance of the Company and may cause the actual results of the Company to differ materially from those anticipated in forward-looking statements. Statements containing forward-looking information reflect management's current beliefs and assumptions based on information in its possession on the date of this news release. Although management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.

The forward-looking statements contained herein are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this news release are made as of the date of this news release and Alaris does not undertake or assume any obligation to update or revise such statements to reflect new events or circumstances except as expressly required by applicable securities legislation.

Conditions for using this site

Alaris Royalty Corp. (“Alaris”) maintains the internet site as an informational service. This site is not intended to supplement or substitute for the legal disclosure for Alaris or for the prospectus disclosure related to a public offering of any of its securities in Canada. Please read the legal notice on the site before you proceed.

Your use of this site is in itself acceptance of the terms and conditions regarding use as stated in the Legal Notice.

U.S. Ownership and Trading Restrictions

To ensure compliance with U.S. securities laws, Alaris’ common shares are subject to a number of ownership and transfer restrictions. Purchases of Alaris common shares are permitted only by non U.S. persons, and in certain private placements to U.S. persons who are “Qualified U.S. Purchasers” and who are not “ERISA Persons”. Information concerning these ownership and transfer restrictions is included in the Investor section of this website under “Ownership and Transfer Restrictions - U.S. Persons.”

The information in this website does not constitute an offering for the sale of securities in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended..

Use of cookies

When you click Agree below, a small amount of data ("a cookie") will be written to your browser, which will enable you to review information contained on this website. The cookie is valid for two days after which you will be again prompted to accept the website legal notice. The use of cookies is very common on commercial websites and web browsers normally accept cookies. If you have turned this function off in your browser's preferences, you will need to turn it on to gain access to this portion of our website. Alaris Royalty Corp. respects your privacy and no personal information is collected or stored as part of this process.